Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloidosis”

1,332 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,332 results

Not applicableStudy completedNCT03420807
What this trial is testing

Retinal Metabolic Imaging of Alzheimer Patient

Who this might be right for
Alzheimer Disease
Optina Diagnostics Inc. 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827768
What this trial is testing

Phase 2 Study of AV-1959R in Individuals With Preclinical Alzheimer's Disease

Who this might be right for
Preclinical Alzheimer's DiseaseAlzheimer Disease
Institute for Molecular Medicine 160
Very early researchEnded earlyNCT03757910
What this trial is testing

Brain Imaging in the Diabetes Prevention Program Outcomes Study

Who this might be right for
Alzheimer Disease
José A. Luchsinger 5
Not applicableLooking for participantsNCT05776641
What this trial is testing

Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People at Risk for Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseFamily Members
Massachusetts General Hospital 200
Large-scale testing (Phase 3)Ended earlyNCT02760602
What this trial is testing

Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 26
Large-scale testing (Phase 3)UnknownNCT04438421
What this trial is testing

Efficacy of Hyaluronic-acid and Hydrogen-Peroxide Mouthwash in Gingivitis Treatment

Who this might be right for
GingivitisBleeding Gum
University of Milan 50
Not applicableStudy completedNCT03842163
What this trial is testing

Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology

Who this might be right for
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Pfizer 812
Not applicableEnded earlyNCT01391377
What this trial is testing

Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
Bayside Health 7
Early research (Phase 1)WithdrawnNCT05519527
What this trial is testing

STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL Amyloidosis

Who this might be right for
Refractory T Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia (AML)
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04991103
What this trial is testing

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

Who this might be right for
Multiple MyelomaAmyloidosis
University of Alabama at Birmingham 40
Not applicableStudy completedNCT02257905
What this trial is testing

Allo SCT in Amyloidosis Non-interventional Study

Who this might be right for
AL Amyloidosis
European Society for Blood and Marrow Transplantation 14
Testing effectiveness (Phase 2)Study completedNCT02595983
What this trial is testing

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

Who this might be right for
Transthyretin (TTR)-Mediated AmyloidosisFamilial Amyloidotic Polyneuropathy (FAP)ATTR Amyloidosis+1 more
Alnylam Pharmaceuticals 12
Early research (Phase 1)Not Yet RecruitingNCT07568041
What this trial is testing

Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients

Who this might be right for
Alzheimer's Disease (AD)
Cenna Biosciences Inc. 54
Not applicableLooking for participantsNCT07154394
What this trial is testing

Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer TypeMild Cognitive ImpairmentCardiac Amyloidosis
University Hospital, Essen 15
Testing effectiveness (Phase 2)Study completedNCT02576639
What this trial is testing

Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 124
Large-scale testing (Phase 3)Study completedNCT04298372
What this trial is testing

Frontline Lenalidomide for AL Amyloidosis Involving Myocardium

Who this might be right for
Amyloidosis Cardiac
Seoul National University Hospital 2
Not applicableEnded earlyNCT06338839
What this trial is testing

Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia

Who this might be right for
Transthyretin Amyloidosis Cardiomyopathy, Heart Failure With Preserved Ejection Fraction
AstraZeneca 1,770
Early research (Phase 1)Study completedNCT00838877
What this trial is testing

Positron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ Amyloid

Who this might be right for
Alzheimer's Disease
AstraZeneca 26
Not applicableStudy completedNCT02055534
What this trial is testing

Nutritional Counseling in Systemic Immunoglobulin Light-chain Amyloidosis

Who this might be right for
Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 144
Not applicableStudy completedNCT03212599
What this trial is testing

Disulfiram as a Modulator of Amyloid Precursor Protein-processing

Who this might be right for
Alcohol Addiction
Johannes Gutenberg University Mainz 17
Next Page